MENU
TRDA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Entrada Therapeutics (TRDA) Ownership - Who owns Entrada Therapeutics?
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible... Show more
Profile
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
219.75M
P/E Ratio
10.11
Total Cash
382.52M
Projected Growth
N/A
Total Debt
57M
Revenue
172.22M
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash/Share
10.08
Total Debt/Equity
N/A
Revenue/Share
4.24 USD as % of share price
Fundamentals
TRDA
Capitalization
220M
P/E Ratio
10.11
Risk (Beta)
0.52
Dividend Yield
N/A
Total Cash
383M
Total Cash/Share
10.08
Total Debt
57M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
4.24%
Revenue
172M
ROE
N/A
Book Value
417M
P/B Ratio
0.53
Cash Flow
N/A
Earnings
0.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
21.88
Current Revenue Per Employee
112338.80
Dividends Per Share - Security
N/A
EBITDA
7.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
4.97
Shares Held By Institutions
375M
Shares Outstanding - Current
38M
Total Liabilities
69.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-66.455
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com